close 74% jaeinvestorite kontodest jääb selle teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse. Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele. CFD-d on keerukad instrumendid, millega kaasneb võimenduse tõttu suur risk kaotada raha kiiresti. 74% jaeinvestorite kontodest jääb selle teenusepakkuja juures CFD-dega kauplemisel kahjumisse. Palume teil kaaluda, kas CFD-de toimimine on teile arusaadav ja kas te olete valmis võtma riski, mis suure tõenäosusega on kahjumlik.
Change languageEesti
Ülevaade

LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

Kodu・Aktsiate loetelu・Seres Therapeutics Inc
Search

Seres Therapeutics Inc

Suletud

SektorTervishoid

18.82 -2.49

Osta

Hinna uuendus 27. aug 2025, 19:59 UTC

OstaMüü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

18.74

Max

19.65

Põhinäitajad

By Trading Economics

Sissetulek

-53M

-20M

Aktsiakasum

-2.27

Kasumimarginaal

-262.454

Töötajad

103

EBITDA

8.4M

-19M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

-27.65% downside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

12. nov 2025

Turustatistika

By TradingEconomics

Turukapital

39M

168M

Eelmine avamishind

21.31

Eelmine sulgemishind

18.82

Uudiste sentiment

By Acuity

40%

60%

132 / 372 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bearish Evidence

N/A / 9.31 Toetus ja vastupanu

Seres Therapeutics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

27. aug 2025, 22:51 UTC

Tulu

Wesfarmers Plans Special Payout to Shareholders as Annual Net Profit Rises 14%

DJ

Loe

27. aug 2025, 23:57 UTC

Tulu

Trip.com Group 1H Rev $4.01B

DJ

Loe

27. aug 2025, 23:57 UTC

Tulu

Trip.com Group 1H Adj EPS $1.84

DJ

Loe

27. aug 2025, 23:57 UTC

Tulu

Trip.com Group 1H EPS $1.82

DJ

Loe

27. aug 2025, 23:50 UTC

Market Talk

Nikkei May Decline Amid Caution Over Tariff Impact, Chip Demand -- Market Talk

DJ

Loe

27. aug 2025, 23:39 UTC

Tulu

Correction to Nvidia Earnings Article -- WSJ

DJ

Loe

27. aug 2025, 22:59 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Loe

27. aug 2025, 22:59 UTC

Market Talk

HP CEO Sees Strong Back-to-School Spending on PCs -- Market Talk

DJ

Loe

27. aug 2025, 22:58 UTC

Tulu

South32 Records Significant Items of $71 Million Tied to Worsley, Mozal

DJ

Loe

27. aug 2025, 22:57 UTC

Tulu

South32 FY Free Cash Flow $192 Million

DJ

Loe

27. aug 2025, 22:56 UTC

Tulu

South32 FY Total Capital Expenditure $1.35 Billion

DJ

Loe

27. aug 2025, 22:56 UTC

Tulu

South32 FY Capital Expenditure $963 Million, Excluding EAIs

DJ

Loe

27. aug 2025, 22:55 UTC

Tulu

South32 Net Cash $123 Million at June 30

DJ

Loe

27. aug 2025, 22:54 UTC

Tulu

South32: Focused on Maintaining Strong Operating Momentum

DJ

Loe

27. aug 2025, 22:53 UTC

Tulu

South32: $144 Million Remains to be Returned to Shareholders Under Program

DJ

Loe

27. aug 2025, 22:53 UTC

Tulu

South32 Extends Capital Management Program for 12 Months

DJ

Loe

27. aug 2025, 22:52 UTC

Tulu

South32 FY Underlying Ebitda $1.93 Billion, Up 7% On-Year

DJ

Loe

27. aug 2025, 22:51 UTC

Tulu

South32 FY Revenue $5.78 Billion, Up 17% On-Year

DJ

Loe

27. aug 2025, 22:51 UTC

Tulu

South32 FY Underlying Earnings $666 Million, Up 75% On-Year

DJ

Loe

27. aug 2025, 22:50 UTC

Tulu

South32 to Pay Final Dividend of 2.6 U.S. Cents/Share

DJ

Loe

27. aug 2025, 22:50 UTC

Tulu

South32 FY Net Profit $213 Million Vs $203 Million Loss Year Earlier

DJ

Loe

27. aug 2025, 22:45 UTC

Tulu

Sandfire Resources Expects FY26 Matsa Capital Expenditure of $148 Million

DJ

Loe

27. aug 2025, 22:44 UTC

Tulu

Sandfire Resources Expects FY26 Motheo Unit Cost of $44/Ton of Ore Processed

DJ

Loe

27. aug 2025, 22:44 UTC

Tulu

Sandfire Resources Expects FY26 Motheo Capital Expenditure of $82 Million

DJ

Loe

27. aug 2025, 22:43 UTC

Tulu

Sandfire Resources Expects FY26 Matsa Unit Cost of $86/Ton of Ore Processed

DJ

Loe

27. aug 2025, 22:43 UTC

Tulu

Nvidia Breaks Sales Record Despite Chinese Trade Hiccups -- 5th Update

DJ

Loe

27. aug 2025, 22:42 UTC

Tulu

Sandfire Resources Expects FY26 Motheo Copper Eq Output to Rise 3% to 61,000 Tons

DJ

Loe

27. aug 2025, 22:42 UTC

Tulu

Sandfire Resources Expects FY26 Matsa Copper Eq Output to Rise 2% to 96,000 Tons

DJ

Loe

27. aug 2025, 22:40 UTC

Tulu

Sandfire Resources Net Debt $123 Million at June 30

DJ

Loe

27. aug 2025, 22:40 UTC

Tulu

Sandfire Resources FY Underlying Ebitda $527.7 Million

DJ

Loe

Võrdlus sarnastega

Hinnamuutus

Seres Therapeutics Inc Prognoos

Hinnasiht

By TipRanks

-27.65% langus

12 kuu keskmine prognoos

Keskmine 14 USD  -27.65%

Kõrge 14 USD

Madal 14 USD

Põhineb 2 Wall Streeti analüütiku instrumendi Seres Therapeutics Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

2 ratings

2

Osta

0

Hoia

0

Müü

Põhineb 2 analüütiku instrumendi Seres Therapeutics Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

N/A / 9.31Toetus ja vastupanu

Lühikene perspektiiv

Bearish Evidence

Recent bearish events outweigh bullish events.

Keskpikk perspektiiv

Bearish Evidence

All events are bearish.

Pikk perspektiiv

Bearish Evidence

All events are bearish.

Sentiment

By Acuity

132 / 372 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Muud aktsiad sektorist

LLY

Eli Lilly and Co.

734.37

↓-0.09%

JNJ

Johnson and Johnson

176.67

↓-0.01%

ABBV

AbbVie Inc

208.05

↓-0.2%

UNH

UnitedHealth Group Inc

303.9

↑ +1.02%

AZN

AstraZeneca PLC ADR

79.94

↓-0.17%